Spaero Bio
- Business Model
- B2B
- Website
- spaero.bio
- Total Funding
- $2.0M
- Last Round
- $2.0M Seed
- Rounds
- 1
About
Spaero Bio develops a robot-agnostic software layer that empowers scientists and automation engineers to design, execute, and iterate liquid-handling protocols faster and with fewer errors. The platform bridges the gap between existing liquid-handler capabilities and laboratory workflow needs, enabling scientists to compose protocol steps through an intuitive UI while automation teams configure operational constraints and error-recovery rules. Spaero's self-healing runtime automatically handles recoverable errors and sends notifications when intervention is needed. Key supported workflows include aliquoting, cherry picking, plate stamping, sample reformatting, and serial dilutions.
Summary
Spaero Bio is a Biotech company. It has raised $2.0M in total across 1 round. Investors include BlueYard Capital, Compound and Cantos.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies

Leading interactive entertainment company and developer of Fortnite, Unreal Engine, and the Epic ...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Cursor is the best way to code with AI, and built to make you extraordinarily productive.
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform


